Agilent Technologies, a Large-Cap Biotechnology stock, moved -0.4% this morning. Here are some facts about the company that we're keeping an eye on:
-
Agilent Technologies has logged a -12.6% 52 week change, compared to 15.1% for the S&P 500
-
A has an average analyst rating of buy and is -9.89% away from its mean target price of $138.17 per share
-
Its trailing earnings per share (EPS) is $4.29, which brings its trailing Price to Earnings (P/E) ratio to 29.0. The Industrials sector's average P/E ratio is 24.03
-
The company's forward earnings per share (EPS) is $5.65 and its forward P/E ratio is 22.0
-
The company has a Price to Book (P/B) ratio of 5.54 in contrast to the Industrials sector's average P/B ratio is 2.89
-
The current ratio is currently 2.1, which consists in its liquid assets divided by any liabilities due within in the next 12 months
-
A has reported YOY quarterly earnings growth of 21.6% and gross profit margins of 0.5%
-
The company's free cash flow for the last fiscal year was $1.37 Billion and the average free cash flow growth rate is 10.5%
-
Agilent Technologies's revenues have an average growth rate of 4.4% with operating expenses growing at 1.2%. The company's current operating margins stand at 22.9%